VANCOUVER, British Columbia and DALLAS–(BUSINESS WIRE)–Alpha Cognition Inc. (NASDAQ:ACOG) (Alpha Cognition, or the Firm), broadcasts that in reference to the Firm’s itemizing on the Nasdaq Capital Market, the Firm will voluntarily delist its widespread shares from the Canadian Securities Change.
The shares will probably be delisted from the Canadian Securities Change on the shut of buying and selling on December 17, 2024. The Firm’s widespread shares will proceed to commerce on Nasdaq underneath the image ACOG.
About Alpha Cognition Inc.
Alpha Cognition Inc. is a commercial-stage biopharmaceutical firm centered on creating therapies for sufferers affected by neurodegenerative illnesses, reminiscent of Alzheimer’s illness and cognitive impairment with delicate traumatic mind damage (mTBI), the place there are presently no accredited therapy choices.
ZUNVEYL is a patented drugs accredited as a next-generation acetylcholinesterase inhibitor (AChEI) for the therapy of Alzheimer’s illness, with minimal anticipated gastrointestinal unintended effects. The energetic metabolite of ZUNVEYL differs from donepezil and rivastigmine in that it enhances the operate of neuronal nicotinic receptors, significantly the alpha-7 subtype, identified to have a optimistic impact on cognition. Benzgalantamine can also be being developed together with memantine to deal with average to extreme Alzheimer’s illness dementia, and as an intranasal formulation for cognitive impairment with mTBI.
Ahead-looking statements: This press launch comprises forward-looking statements inside the that means of relevant securities legal guidelines. Aside from statements of historic truth, any info contained on this press launch could represent a forward-looking assertion that displays the Firm’s present views relating to future occasions and is topic to identified dangers, uncertainties, assumptions and different components. unknowns that will trigger the precise outcomes. , ranges of exercise, efficiency or achievements ought to be materially completely different from the data expressed or implied by such forward-looking statements. Though the Firm believes that every forward-looking assertion has an inexpensive foundation, we warning you that such statements are primarily based on a mix of details and components presently identified to us and our expectations relating to the longer term, which we can’t be sure. The Firm can not assure that precise outcomes will probably be according to these forward-looking statements. These forward-looking statements communicate solely as of the date of this press launch and the Firm undertakes no obligation to revise or replace any forward-looking statements for any cause, even when new info turns into obtainable sooner or later.
View supply model on businesswire.com: https://www.businesswire.com/information/house/20241212186439/en/
For extra info:
Michael McFadden, CEO
Tel: 1-858-344-4375
data@alphacognition.com
Supply: Alpha Cognition Inc.
#Alpha #Cognition #broadcasts #voluntary #delisting #CSE #Investing.com , #Gossip247
,
